United States

Back to map

Showing 251-260 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Antigenic Targets of CD4 T cells across the stages of type 1 diabetes Regents of the University of Colorado Maki Nakayama Cures 01-August-2022 to 31-July-2026 $750.000,00
Mapping islet-reactive T cell responses by islet cell co-culture Trustees of the University of Pennsylvania Michael Betts Cures 01-July-2022 to 30-June-2025 $825.000,00
Expanding Technology Success into Novel Populations: Safety and Feasibility Testing of a Fully Closed Loop System in Adolescents and Young Adults with High Baseline HbA1c Values Regents of the University of Colorado Gregory Forlenza Improving Lives 01-November-2022 to 30-June-2025 $999.996,26
Localized immune modulation to enable long-term beta cell survival William Marsh Rice University Omid Veiseh Cures 01-September-2022 to 31-August-2025 $600.000,00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273.424,00
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes Minutia Katy Digovich Cures 01-November-2022 to 30-November-2025 $1.198.600,00
Discovering early diagnostic markers of cardiovascular disease risk with lipidomics in a 30-year longitudinal prospective type 1 diabetes cohort University of Wisconsin-Madison (Board of Regents University of Wisconsin System) Judith Simcox Improving Lives 01-November-2022 to 31-October-2025 $799.988,63
Development of a new nanotechnology for immune-tolerizing therapy against T1D EVOQ Therapeutics, Inc. Vishalakshi Krishnan Cures 01-September-2022 to 28-February-2026 $1.110.000,00
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes Mayo Clinic Naureen Javeed Cures 01-September-2022 to 31-August-2025 $400.000,00
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population Geisinger Clinic David Carey Cures 01-November-2022 to 31-October-2025 $1.469.640,10